UNIVERSIDAD NACIONAL DE LA PLATA

Bibliografía
Corwin RL, Boan J, Peters KF, Ulbrecht JS (2012) Baclofen reduces binge eating in a double‐blind,
placebo‐controlled, crossover study. Behavioural pharmacology 23:616‐625.
Corwin RL, Buda‐Levin A (2004) Behavioral models of binge‐type eating. Physiology & behavior
82:123‐130.
Cottone P, Sabino V, Roberto M, Bajo M, Pockros L, Frihauf JB, Fekete EM, Steardo L, Rice KC,
Grigoriadis DE, Conti B, Koob GF, Zorrilla EP (2009) CRF system recruitment mediates
dark side of compulsive eating. Proceedings of the National Academy of Sciences of the
United States of America 106:20016‐20020.
Cottrell E, Mercer JG (2012) Leptin receptors. In: Appetite Control, vol. 209 (Joost, H.‐G., ed):
Springer.
Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ (2001)
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate
nucleus. Nature 411:480‐484.
Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier
M, Esterman M, Heiman ML, Garcia‐Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P,
Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL (2003) The distribution
and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic
circuit regulating energy homeostasis. Neuron 37:649‐661.
Crawley JN (1999) Behavioral phenotyping of transgenic and knockout mice: experimental
design and evaluation of general health, sensory functions, motor abilities, and specific
behavioral tests. Brain research 835:18‐26.
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS (2001) A preprandial rise
in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714‐
1719.
Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002) Plasma
ghrelin levels after diet‐induced weight loss or gastric bypass surgery. The New England
journal of medicine 346:1623‐1630.
Currie PJ, Khelemsky R, Rigsbee EM, Dono LM, Coiro CD, Chapman CD, Hinchcliff K (2012) Ghrelin
is an orexigenic peptide and elicits anxiety‐like behaviors following administration into
discrete regions of the hypothalamus. Behavioural brain research 226:96‐105.
Chaudhri N, Sahuque LL, Schairer WW, Janak PH (2010) Separable roles of the nucleus
accumbens core and shell in context‐ and cue‐induced alcohol‐seeking.
Neuropsychopharmacology : official publication of the American College of
Neuropsychopharmacology 35:783‐791.
Chen C, Wu D, Clarke IJ (1996) Signal transduction systems employed by synthetic GH‐releasing
peptides in somatotrophs. The Journal of endocrinology 148:381‐386.
Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ,
Feighner SD, Guan XM, Ye Z, Nargund RP, Smith RG, Van der Ploeg LH, Howard AD,
MacNeil DJ, Qian S (2004) Orexigenic action of peripheral ghrelin is mediated by
neuropeptide Y and agouti‐related protein. Endocrinology 145:2607‐2612.
Chuang JC, Perello M, Sakata I, Osborne‐Lawrence S, Savitt JM, Lutter M, Zigman JM (2011)
Ghrelin mediates stress‐induced food‐reward behavior in mice. The Journal of clinical
investigation 121:2684‐2692.
Chuang JC, Zigman JM (2010) Ghrelin's Roles in Stress, Mood, and Anxiety Regulation.
International journal of peptides 2010.
Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A, Shivers BD, Seeburg PH (1989)
The dopamine D2 receptor: two molecular forms generated by alternative splicing.
EMBO J 8:4025‐4034.
138